MedPath

Ropivacaine heavy 0.75% vs Bupivacaine heavy 0.5% in infraumbilical surgeries for duration of analgesia

Phase 3
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/03/064555
Lead Sponsor
Jawahar lal nehru medical college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Body weight 40 to 80 kg

2. ASA class I and II

3. patients undergoing infraumblical surgeries

Exclusion Criteria

1.Patients refusal and uncooperative patients

2.Hypersensitivity to study drugs

3. local site infection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
duration of analgesiaTimepoint: pain will be assessed using Visual Analogue Score in immediate postoperative period follwoed by hourly interval till 24 hrs post opertively
Secondary Outcome Measures
NameTimeMethod
1. onset and duration of sensory block <br/ ><br>2.onset and duration of motor block <br/ ><br>3. hemodynamic changes and adverse effectsTimepoint: 1.using hypodermic needle immediately after spinal, every 2 minutes till 10minut, every 5minute till 60minute then every hour till 6 hour in post operative period then every 6hour till 24 hour. <br/ ><br> <br/ ><br>2.Assessed using Bromage score immediately after spinal, every 2 minutes till 10minut, every 5minute till 60minute then every hour till 6 hour in post operative period then every 6hour till 24 hour.
© Copyright 2025. All Rights Reserved by MedPath